Showing posts with label Mortality. Show all posts
Showing posts with label Mortality. Show all posts

Friday, 6 December 2013

Day 70: My Hospital Guide 2013

At 1.00am on Monday morning Dr Foster Intelligence will publish My Hospital Guide 2013 online with a focus this year on commissioning and mortality.

I doubt many, if any, of you will be staying up until 1.00am to read it immediately, but it is important to you.  This is data made publicly available about your local hospital and CCG; you should be interested in how well they perform.


The Guide is user friendly and is your opportunity to understand a bit more about the quality of your local NHS.  If it prompts further questions from you, ask your local NHS.

Thursday, 24 October 2013

Day 39: The Dog That Doesn’t Bark

“The dog that doesn't bark” was jargon used today (new one to me) to describe a 'measure' that suggests there may be no problem, but behind the measure there are problems!

This was at an Area Team Mortality Workshop today to locally share best practise and learn from Sir Bruce Keogh’s Mortality Reviews of 14 hospitals. Very helpful presentation about the different measures that are used to monitor mortality in hospitals, including the benefits and pitfalls of each.  If you want to know the difference between your SHMI, HSMR or RAMI, Advancing Quality Alliance have written a good paper.

Data is important, but, as the jargon suggests, much more important to work together locally across organisations within a local community and to look at mortality from a patient perspective, not being constrained by corporate boundaries. This needs to include the components of quality (as defined by Lord Darzi & expanded by Don Berwick):
  • Safety (avoiding harm from the care that is intended to help).
  • Effectiveness (aligning care with science and ensuring efficiency).
  • Patient-experience (including patient-centeredness, timeliness and equity)

 We need to locally develop an approach to reviewing mortality at a patient, organisation, pathway, community and population level that is based on best evidence from England and internationally.  Also, and probably most importantly, we must engage with and involve patients and carers in the design and use of this process.  This will also help in communicating what we’re doing to the public to provide clear transparent messages that include appropriate reassurance.

(sorry, wrote 200 words today; could have written much more, such an important and interesting subject)